Skip to content

Endovascular exclusion technique for the treatment of complex basis cranii vessel wall defects: a prospective, multi-center clinical trial

Endovascular exclusion technique for the treatment of complex basis cranii vessel wall defects: a prospective, multi-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017756
Enrollment
Unknown
Registered
2018-08-13
Start date
2018-10-30
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

complex basis cranii vessel wall defects

Interventions

Case series:covered stent insertion

Sponsors

Shanghai Tongji Hospital, Tongji University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Cerebral angiography examinations confirmed complicated cerebral aneurysms (wide-necked/large or giant/ pseudo-aneurysm) at internal or vertebral arteries; 2) Wide-necked aneurysm is considered as the neck width =4mm or fundus-to-neck ratio <2; large or giant aneurysms are defined as the maximum aneurysm diameter between 10~25 mm or =25mm; Pseudo-aneurysm is considered definitely caused by trauma, iatrogenic injury or radiotherapy et al.; 3) Diameter of the parent artery is between 3.5-4.5mm; 4) Researchers believe patients is suitable to receive WILLIS covered stent treatment; 5) Patients volunteered to conduct the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Important side branches originate from the target aneurysm, including anterior choroidal artery, embryonic type of the posterior communicating artery and posterior inferior cerebellar artery; 2) No appropriate vessel routes or extremely tortuous parent arteries; 3) Sever coagulation disorders, dysfunction of the heart, liver or kidney or systemic infection; 4) Life expectancy <1 year; 5) There are contraindications for heparin, aspirin, clopidogrel, anaesthesia, contrast media or X-ray.

Design outcomes

Primary

MeasureTime frame
Aneurysm total occlusion rate;

Secondary

MeasureTime frame
patency of parent artery;procedure related safty;

Countries

China

Contacts

Public ContactChun Fang

Shanghai Tongji Hospital, Tongji University School of Medicine

fang1972@vip.sina.com+86 13402099739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026